Olanzapine/fluoxetine (Symbyax®) is an oral once-daily fixed-dose combination of the atypical antipsychotic olanzapine and the selective serotonin reuptake inhibitor (SSRI) fluoxetine that is approved in the US for the treatment of depressive episodes associated with bipolar disorder in adults. Combin...
a few case reports and one noncomparative study have suggested some efficacy in the treatment of children with bipolar disorder. According to retrospective chart reviews and case reports olanzapine, when combined with mood stabilisers